Bank of Montreal’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $277K | Buy |
11,202
+1,398
| +14% | +$33.3K | ﹤0.01% | 2720 |
|
|
2025
Q4 | $229K | Buy |
+9,804
| New | +$218K | ﹤0.01% | 2760 |
|
|
2025
Q3 | – | Sell |
-20,594
| Closed | -$447K | – | 3576 |
|
|
2025
Q2 | $447K | Buy |
20,594
+851
| +4% | +$20.1K | ﹤0.01% | 2344 |
|
|
2025
Q1 | $479K | Buy |
19,743
+4,864
| +33% | +$110K | ﹤0.01% | 2226 |
|
|
2024
Q4 | $311K | Buy |
14,879
+875
| +6% | +$18.8K | ﹤0.01% | 2530 |
|
|
2024
Q3 | $274K | Buy |
14,004
+461
| +3% | +$8.55K | ﹤0.01% | 2842 |
|
|
2024
Q2 | $210K | Buy |
13,543
+149
| +1% | +$2.32K | ﹤0.01% | 2974 |
|
|
2024
Q1 | $216K | Buy |
13,394
+1,921
| +17% | +$28.9K | ﹤0.01% | 3006 |
|
|
2023
Q4 | $198K | Buy |
+11,473
| New | +$157K | ﹤0.01% | 3141 |
|
|
2023
Q2 | – | Sell |
-12,772
| Closed | -$213K | – | 4010 |
|
|
2023
Q1 | $213K | Buy |
+12,772
| New | +$211K | ﹤0.01% | 2977 |
|
|
2021
Q4 | – | Sell |
-593,007
| Closed | -$3.07M | – | 3549 |
|
|
2021
Q3 | $3.07M | Sell |
593,007
-32,269
| -5% | -$176K | ﹤0.01% | 1867 |
|
|
2021
Q2 | $3.61M | Buy |
625,276
+286,155
| +84% | +$1.48M | ﹤0.01% | 1765 |
|
|
2021
Q1 | $1.5M | Sell |
339,121
-993
| -0.3% | -$3.94K | ﹤0.01% | 1924 |
|
|
2020
Q4 | $1.17M | Buy |
340,114
+61,504
| +22% | +$207K | ﹤0.01% | 2130 |
|
|
2020
Q3 | $867K | Sell |
278,610
-20,252
| -7% | -$79.2K | ﹤0.01% | 2047 |
|
|
2020
Q2 | $1.5M | Buy |
298,862
+143,846
| +93% | +$646K | ﹤0.01% | 1760 |
|
|
2020
Q1 | $561K | Sell |
155,016
-1,881
| -1% | -$7.72K | ﹤0.01% | 1925 |
|
|
2019
Q4 | $588K | Buy |
156,897
+143,434
| +1,065% | +$671K | ﹤0.01% | 2572 |
|
|
2019
Q3 | $72K | Buy |
13,463
+510
| +4% | +$2.72K | ﹤0.01% | 3455 |
|
|
2019
Q2 | $50K | Buy |
12,953
+7,953
| +159% | +$34.4K | ﹤0.01% | 3688 |
|
|
2019
Q1 | $26K | Sell |
5,000
-1,361
| -21% | -$4K | ﹤0.01% | 3574 |
|
|
2018
Q4 | $13K | Buy |
6,361
+695
| +12% | +$1.99K | ﹤0.01% | 3789 |
|
|
2018
Q3 | $22K | Sell |
5,666
-19
| -0.3% | -$60 | ﹤0.01% | 3675 |
|
|
2018
Q2 | $18K | Buy |
5,685
+685
| +14% | +$2.08K | ﹤0.01% | 3773 |
|
|
2018
Q1 | $12K | Buy |
+5,000
| New | +$16.6K | ﹤0.01% | 3698 |
|
|
2017
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 4000 |
|
|
2016
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 3952 |
|
|
2016
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 3918 |
|
|
2016
Q2 | $1K | Sell |
1,000
-1,500
| -60% | -$1.21K | ﹤0.01% | 3967 |
|
|
2016
Q1 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 3902 |
|
|
2015
Q4 | $6K | Hold |
2,500
| – | – | ﹤0.01% | 3742 |
|
|
2015
Q3 | $8K | Buy |
2,500
+1,000
| +67% | +$4.32K | ﹤0.01% | 3529 |
|
|
2015
Q2 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 3587 |
|
|
2015
Q1 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 3587 |
|
|
2014
Q4 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 3733 |
|
|
2014
Q3 | $5K | Hold |
1,500
| – | – | ﹤0.01% | 3791 |
|
|
2014
Q2 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 4241 |
|
|
2014
Q1 | $3K | Hold |
1,500
| – | – | ﹤0.01% | 3862 |
|
|
2013
Q4 | $3K | Buy |
+1,500
| New | +$3.03K | ﹤0.01% | 3587 |
|
Other funds holding CPRX
VCM
DM
VPM
Bank of Montreal's CPRX Position: Q1 2026 in Review
Bank of Montreal increased its Catalyst Pharmaceutical (CPRX) stake by 14% in Q1 2026, buying an estimated $33.3K and bringing the position to 11,202 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2720.
Bank of Montreal first reported a position in CPRX in Q4 2013 and has held it in 38 quarters since. The position peaked at $3.61M in Q2 2021. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Bank of Montreal held 11,202 shares of Catalyst Pharmaceutical worth $277K as of Q1 2026.
- Bank of Montreal bought 1,398 Catalyst Pharmaceutical shares in Q1 2026, an estimated $33.3K.
- Catalyst Pharmaceutical made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2720 holding.
- Bank of Montreal first reported a position in Catalyst Pharmaceutical in Q4 2013 and has held it in 38 quarters since.
- Bank of Montreal's Catalyst Pharmaceutical position peaked at $3.61M in Q2 2021.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.